Synthesis and biological evaluation of some new A,B-ring modified steroidal d-lactones

Steroids

Volumn 73, Issue 6, 2008, Pages 681-688

  Djurendić, Evgenija A ^a   Sakač, Marija N ^a   Zaviš, Marina P ^a   Gaković, Andrea R ^a   Čanadi, Janoš J ^a   Andrić, Silvana A ^a   Klisurić, Olivera R ^a   Kojić, Vesna V ^b   Bogdanović, Gordana M ^b   Gaši, Katarina M Penov ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b ONCOLOGY INSTITUTE OF VOJVODINA   (Serbia)

Author keywords

Aromatase inhibitor; In vitro cytotoxicity; Steroidal epoxides; Steroidal lactones; X ray analysis

Indexed keywords

17A HOMOLACTONE DERIVATIVE; 3 CHLOROPERBENZOIC ACID; 4ALPHA EPOXIDE; 4BETA EPOXIDE; 5ALPHA EPOXIDE; 5BETA EPOXIDE; LACTONE DERIVATIVE; STEROIDAL DEXTRO LACTONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; OXIDATION; PROSTATE CANCER; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

CELL LINE, TUMOR; CRYSTALLOGRAPHY, X-RAY; CYCLIZATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LACTONES; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; OXIDATION-REDUCTION; STEROIDS;

EID: 41649097931     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2008.02.006     Document Type: Article

References (17)

1. Ray S., Tandon A., Dwivedy I., Kilgore Wilson S.R., O'Neil J.P., and Katzenellenbogen J.A. An X-ray crystallographic study of the nonsteroidal contraceptive agent centchroman. J Med Chem 37 (1994) 696-700
2. Santen R.J. Inhibition of aromatase: insights from recent studies. Steroids 68 (2003) 559-567
3. Santen R.J., Manni A., Harvey H., and Redmond C. Endocrine treatment of breast cancer in women. Endocr Rev 11 (1990) 221-265
4. Yue W., Mor G., Naftolin F., Pauley R., Shim W.-S., Harvey H.A., et al. Aromatase inhibitors in breast cancer. In: Robertson J.F.R., Nicholson R.I., and Hayes D.F. (Eds). Endocrine therapy of breast cancer (2002), Martin Dunitz Ltd. Publishers, London, England 75-106
5. Coombes R.C., Hughes S.W., and Dowsett M. 4-Hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancer. Eur J Cancer 28A (1992) 1941-1945
6. Numazawa M., and Yamaguchi S. Synthesis and structure-activity relationships of 6-phenylaliphatic-substituted C19 steroids having a 1,4-diene, 4,6-diene or 1,4,6-triene structure as aromatase inhibitors. Steroids 64 (2001) 187-196
7. Numazawa M., Yamada K., Nitta S., Sasaki C., and Kidokoro K. Role of hydrophilic interaction in binding of hydroxylated 3-deoxy C19 steroids to the active site of aromatase. J Med Chem 44 (2001) 4277-4283
8. Nagaoka M., Watari Y., Yajima H., Tsukioka K., Muroi Y., Yamada K., et al. Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors, synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids. Steroids 68 (2003) 533-542
9. Cepa M.M.D.S., Tavares da Silva E.J., Correia-da-Silva G., Roleira F.M.F., and Teixeira N.A.A. Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation. J Med Chem 48 (2005) 6379-6385
10. Penov Gaši K., Stojanović S., Sakač M., Popsavin M., Jovanović Šanta S., Stanković S., et al. Synthesis and anti-aromatase activity of some new steroidal d-lactones. Steroids 70 (2005) 47-53
11. Penov Gaši K., Sakač M., Djurendić E., Csanadi J., Molnar Gabor D., Lazar D., et al. Synthesis and biological activity of some 17a-substituted homolactones of androst-5-ene derivatives. Collect Czech Chem Commun 70 (2005) 1387-1396
12. Santafé G., Paz V., Rodríguez J., and Jiménez C. Novel cytotoxic oxigenated C29 sterols from the Colombian marine sponge Polymastia tenax. J Nat Prod 65 (2002) 1161-1164
13. Sheldrick G.M. SHELX97 (1997), University of Göttingrn, Germany
14. Penov Gaši K., Stanković S., Csanadi J., D{combining short stroke overlay}urendić E., Sakač M., Medić-Mijačević L., et al. New d-modified androstane derivatives as aromatase inhibitors. Steroids 66 (2001) 645-653
15. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82 (1990) 1107-1112
16. Sotto A., Foulongne V., Sirot D., Labia R., and Jourdan J. Experimental application of the median-effect principle for in vitro quantification of the combined inhibitory activities of clavulanic acid and imipenem against IRT-4 β-lactamase. Int J Antimicrob Agents 19 (2002) 75-78
17. Farrugia L.J. WinGX suite for small-molecule single-crystal crystallography. J Appl Crystallogr 32 (1999) 837-838